Haemonetics Corp (NYSE:HAE)
| 83.27 Delayed Data As of May 26 |  +0.39 / +0.47%Today’s Change | 58.23 Today|||52-Week Range 91.39 | +5.87% Year-to-Date |
Latest HAE News | Press Releases
| How Much Upside is Left in Haemonetics (HAE)? Wall Street Analysts Think 27.09% May 26 / Zacks.com - Paid Partner Content | HAE or PODD: Which Is the Better Value Stock Right Now? May 22 / Zacks.com - Paid Partner Content |
| New Strong Buy Stocks for May 26th May 26 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 82.88 |
| Today’s open | 82.86 |
| Day’s range | 82.38 - 83.91 |
| Volume | 201,256 |
| Average volume (3 months) | 351,097 |
| Market cap | $4.2B |
Data as of 4:00pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +167.44% |
| Earnings growth (this year) | +18.32% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | +17.67% |
| P/E ratio | 37.1 |
| Price/Sales | 3.64 |
| Price/Book | 5.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICUIICU Medical Inc | -1.05 | -0.60% |
| MMSIMerit Medical System... | +0.45 | +0.56% |
| CNMDConmed Corp | +0.94 | +0.80% |
| ---- |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 8, 2023 |
| EPS forecast (this quarter) | $0.73 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $115.4M |
| Net profit margin | 9.87% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
